The global mRNA market is expanding beyond COVID-19, with growing focus on oncology and rare diseases. Advances in lipid nanoparticle delivery, personalized therapies, and regulatory support drive innovation, while strategic collaborations enhance development and market growth. More Info: https://www.imarcgroup.com/mrna-vaccines-therapeutics-market